Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300069349Phase 4Not yet recruiting
Phase 4, open-label trial of esketamine in acute pain and chronic stress (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Post Traumatic Stress Disorder Self-Rating Scale score. Planned start Mar 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300069349.